Clinical Trials Logo
  1. Home
  2. Parkinson
  3. NCT02539784

Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease — SpinalPark  

Parkinson Clinical Trial

Official title:
Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease: A Phase I Safety and Efficacy Study

Clinical Trial Summary

Following the so call "honey moon" period, motor symptoms of Parkinson's Disease (PD) become difficult to control with dopaminergic treatments alone. Deep brain stimulation (DBS) of the subthalamic nucleus and internal globus pallidus helps to treat fluctuating parkinsonian patients restoring a decent quality of life. However, DBS need a long, complex and invasive surgery to succeed. Thus, there is a critical need to develop alternative treatments, more accessible and less invasive. Thoracic posterior spinal cord stimulation has been used for decades to treat chronic neuropathic pains. Safety and efficacy have already been demonstrated in neuropathic pain. Experimentally, SCS has also demonstrated to improve locomotor activity in two different rodents' models of parkinson's disease. The purpose of this study is to determine whether thoracic SCS is safe and could induce a benefit motor parkinsonian symptoms without any impact on cognitive function and axial disability.

Clinical Trial Description

The present pilot study will enroll 6 patients suffering from advanced Parkinson Disease (PD). Investigator will assess the safety, tolerance and efficacy of Spinal Cord Stimulation (SCS) with frequencies of 50, 100 and 130 Hz in a shuffle randomized for each patient. Briefly, each frequency will be evaluated immediately after and 4 weeks following SCS initiation with UPDRS-III, pain scales, and Hauser's diary. The best frequency for each patient will be then selected and maintained activated for 12 additional weeks. At the end of these 12 weeks, new assessment including UPDRS, visual pain scale, "SAINT-ANTOINE" Pain Questionary, PDQ-39 (quality of life), daily L-dopa equivalent dose, MDRS (cognitive status), LARS (apathy status) and MADRS (depression status) will be compared to the inclusion data of each patient. Primary endpoints include the safety of thoracic SCS by collected the number of adverse event and the efficacy by measuring the UPDRS-III OFF med/ON stim at 30 weeks. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02539784
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Claire Thiriez, MD
Phone (0)1 49 81 53 04
Email claire.thiriez@hmn.aphp.fr
Status Recruiting
Phase Phase 1/Phase 2
Start date June 2015
Completion date January 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA® Phase 1
Recruiting NCT01537224 - Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information N/A
Withdrawn NCT04011449 - State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With DBS Using the Medtronic RC+S N/A
Completed NCT02539446 - Suprapostural Attention Focus and Postural Difficulty on H-reflex and Brain Activity: Aging and Parkinson's Disease N/A
Completed NCT00358189 - Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease N/A
Active, not recruiting NCT04606979 - tDCS of the Primary Motor Cortex to Improve Implicit Motor Sequence Learning in Parkinson's Disease N/A
Completed NCT05119803 - The Relationship of Spine Posture and Mobility With Upper Extremity Functions in Parkinson's Patients
Recruiting NCT06154772 - Quality of Life, Anxiety and Fatigue Level of Parkison's Patients With Color Therapy N/A
Not yet recruiting NCT02249715 - Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease N/A
Completed NCT01732653 - A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults N/A
Completed NCT03232996 - Evaluation of a Computer Game Based Rehabilitation System for Assessment and Treatment of Balance and Gait Impairments in Individuals With Parkinson's Disease. N/A
Enrolling by invitation NCT04566341 - Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease
Active, not recruiting NCT04978597 - Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) Phase 3
Recruiting NCT06116084 - Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine N/A
Recruiting NCT05830396 - GRoningen Early-PD Ambroxol Treatment Phase 2/Phase 3
Not yet recruiting NCT05379062 - Choral Singing for Patients With Parkinson's N/A
Completed NCT02071823 - Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules Phase 1
Recruiting NCT03558568 - The Effect of Deep Brain Stimulation on Facial Expressions. N/A
Enrolling by invitation NCT05596201 - Super-resolution of Brain Magnetic Resonance Images in Deep Brain Stimulation for Parkinson's Disease
Recruiting NCT04181918 - Action Observation Treatment in Parkinson's Patients N/A